Confirmed growth for Hygie31

Despite a challenging economic and health environment, Hygie31 pursued its development in 2024 with record turnover of 3.3 billion euro (+22% in relation to 2023). This success is based on an incomparable model that integrates an overall, virtuous, innovative healthcare ecosystem, which ensures the Group's staying power and expansion. As such, Hygie31 ranks as a pivotal healthcare player in Europe.

With 1,519 points of sale (+19%), i.e. +244 new points of sale, Hygie31 confirms its leadership role:

Thanks to its incomparable model, Hygie31 provides support for all types of pharmacist: :

Its digital branch business has remained stable with turnover of 91 million euro through 4 sites specialized in Healthcare, wellness and Medical Equipment.

The Group's one-of-a-kind omnichannel strategy combines the strength of its in-store presence and in-depth digital expertise. Thanks to its innovative logistics investments made in 2024 that are unparalleled on the healthcare market, the Group has taken a decisive step forward in supporting healthcare professionals and consumers while ensuring access to Healthcare is easier for everyone.

Via its virtuous ecosystem where every subsidiary generates value and contributes to the Group's development, Hygie 31 illustrates its ability to address today's healthcare challenges while preparing for tomorrow.
Pharmacists have confirmed their status as Doctors and are now the first healthcare point of contact in towns.

2025: Hygie31 continues to grow rapidly

Although Hygie31 chose to consolidate its ecosystem and organization in 2023-2024, the Group continues to step up the pace and plans to harness synergies to boost performance.

By focusing on increasing sales volumes, integrating artificial intelligence into its management and incorporating new acquisitions, Hygie31 targets 3.7 billion euro in turnover and 1,752 points of sale.